Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
01 6Supriya Lifescience
02 3Apotex Inc
03 196Novo Nordisk
04 6Pharmathen SA
05 1Supremeuni
06 2Titan Laboratories
07 2Wanbang Biopharmaceuticals
01 10Flextouch Injectable Solution In Pre-Filled Pen
02 3INJECTION;SOLUTION
03 8Injectable Solution
04 15Injectable Solution In Pre-Filled Pen
05 3Injection
06 1Injection For Subcutaneous Use
07 7PED
08 8SOLUTION
09 18SOLUTION;SUBCUTANEOUS
10 67Solution For Injection
11 5Subcutaneous Pen
12 6TABLET
13 12TABLET;ORAL
14 47Tablet
15 6Blank
01 16Allowed
02 25Approved
03 31Authorized
04 1DISCN
05 1Deregistered
06 12Marketed
07 7Not Marketed
08 7Originator
09 6PRESCRIPTION
10 47Prescription
11 19RX
12 8SCHEDULE D
13 4USA
14 32Blank
01 1Kyinsu
02 13OZEMPIC
03 44Ozempic
04 1Ozempic DualDose
05 2Ozempic FixDose
06 11RYBELSUS
07 41Rybelsus
08 3SEMAGLUTIDE
09 1Semaglutide Injection
10 19WEGOVY
11 1WEGOVY HD
12 31Wegovy
13 1Wegovy 0,25 mg
14 1Wegovy 0,5 mg
15 1Wegovy 1 mg
16 1Wegovy 1,7 mg
17 1Wegovy 2,4 mg
18 5Wegovy FixDose
19 6Wegovy Flex Touch
20 11Wegovy Flextouch
21 5Wegovy Multi FixDose
22 16Blank
01 6Australia
02 14Canada
03 2China
04 25Denmark
05 22Estonia
06 6Greece
07 8India
08 1Malaysia
09 19Norway
10 7South Africa
11 31Spain
12 26Sweden
13 16Switzerland
14 33USA
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Subcutaneous Pen
Dosage Strength : 0.25MG/0.5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Subcutaneous Pen
Dosage Strength : 0.5MG/0.5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Subcutaneous Pen
Dosage Strength : 1MG/0.5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Subcutaneous Pen
Dosage Strength : 1.7MG/0.75ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Subcutaneous Pen
Dosage Strength : 2.4MG/0.75ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 14MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : OZEMPIC
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 2MG/1.5ML (1.34MG/ML)
Packaging :
Approval Date : 2017-12-05
Application Number : 209637
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OZEMPIC
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 4MG/3ML (1.34MG/ML)
Packaging :
Approval Date : 2019-04-09
Application Number : 209637
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OZEMPIC
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 8MG/3ML (2.68MG/ML)
Packaging :
Approval Date : 2022-03-28
Application Number : 209637
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OZEMPIC
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 2MG/3ML (0.68MG/ML)
Packaging :
Approval Date : 2022-10-06
Application Number : 209637
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : OZEMPIC
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.25MG/0.5ML (0.25MG/0.5ML)
Packaging :
Approval Date :
Application Number : 209637
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : OZEMPIC
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.5MG/0.5ML (0.5MG/0.5ML)
Packaging :
Approval Date :
Application Number : 209637
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : OZEMPIC
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1MG/0.5ML (1MG/0.5ML)
Packaging :
Approval Date :
Application Number : 209637
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RYBELSUS
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2019-09-20
Application Number : 213051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RYBELSUS
Dosage Form : TABLET;ORAL
Dosage Strength : 7MG
Packaging :
Approval Date : 2019-09-20
Application Number : 213051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RYBELSUS
Dosage Form : TABLET;ORAL
Dosage Strength : 14MG
Packaging :
Approval Date : 2019-09-20
Application Number : 213051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OZEMPIC
Dosage Form : TABLET;ORAL
Dosage Strength : 1.5MG
Packaging :
Approval Date : 2024-12-09
Application Number : 213051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OZEMPIC
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2024-12-09
Application Number : 213051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OZEMPIC
Dosage Form : TABLET;ORAL
Dosage Strength : 9MG
Packaging :
Approval Date : 2024-12-09
Application Number : 213051
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RYBELSUS
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number : 213182
Regulatory Info :
Registration Country : USA
